Fact CheckerSign in

NCT07022886Active, not recruiting

INCIDENCE, PREVALENCE AND OVERALL RISK OF ESOPHAGEAL CANCER IN ACHALASIA: A PROPENSITY-MATCHED POPULATION-BASED STUDY FROM A LARGE MULTICENTER DATABASE

Source: ClinicalTrials.gov · Last updated 30 Jul 2025

Brief summary (registry, in English)

Esophageal Achalasia has been investigated as a potential risk factor for esophageal cancer (EC). Longstanding disease, repeated treatment, age and male sex seem the most relevant risk factors, but no clear effect size estimation from large sample cohorts has been provided so far. The aim of the investigators is to estimate EC risk in large sample-size population, and to provide sub-analyses per cancer type and treatment impact on EC risk.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
47000 (actual)
First submitted
8 Jun 2025
Start date
3 Jun 2025
Primary completion date
3 Jun 2025
Lead sponsor
IRCCS San Raffaele
NCT number
NCT07022886

What you commit to

  • Study type: Observational
  • Participants enrolled: 47000
  • From 3 Jun 2025 to the primary completion date, 3 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Primary esophaeal and pharyngeal motility disorders (ICD-10-J39.2)

Who the study is looking for

  • Esophageal achalasia diagnosed according to guidelines (ICD-10-K22.0)

Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
IRCCS San Raffaele Hospital
Coordinator of this site? Confirm its status
MilanItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.